(Q42233712)

19 October 2017

Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells (English)

1 reference

19 October 2017

8

1 reference

19 October 2017

J J Pen

1

1 reference

19 October 2017

B D Keersmaecker

2

1 reference

19 October 2017

C Heirman

3

1 reference

19 October 2017

J Corthals

4

1 reference

19 October 2017

T Liechtenstein

5

1 reference

19 October 2017

D Escors

6

1 reference

19 October 2017

K Thielemans

7

1 reference

19 October 2017

9 January 2014

1 reference

19 October 2017

1 reference

19 October 2017

21

1 reference

19 October 2017

3

1 reference

19 October 2017

262-271

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2013.80

19 October 2017

0 references

cites work

Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Viral immune evasion due to persistence of activated T cells without effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

The PD-1 pathway in tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Regulatory T-cell expansion during chronic viral infection is dependent on endogenous retroviral superantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Targeting PD-1/PD-L1 interactions for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Restoring function in exhausted CD8 T cells during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Current approaches in dendritic cell generation and future implications for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Alternative splice variants of the human PD-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Identification of a novel splice variant of human PD-L1 mRNA encoding an isoform-lacking Igv-like domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Generation of large numbers of dendritic cells in a closed system using Cell Factories.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

7 January 2021

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

7 January 2021

Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

7 January 2021

CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

7 January 2021

Lentivirally transduced dendritic cells as a tool for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

7 January 2021

Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

7 January 2021

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

7 January 2021

Dendritic cells differentiated in the presence of IFN-β and IL-3 are potent inducers of an antigen-specific CD8+ T cell response

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.80

7 January 2021

Identifiers

DOI

10.1038/GT.2013.80

1 reference

Dimensions Publication ID

19 October 2017

0 references

1 reference